Cargando…
Dual‐Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy
Improvement of the accuracy of dosimetry in radionuclide therapy has the potential to increase patient safety and therapeutic outcomes. Although positron emission tomography (PET) is ideally suited for acquisition of dosimetric data because PET is inherently quantitative and offers high sensitivity...
Autores principales: | Wurzer, Alexander, Seidl, Christof, Morgenstern, Alfred, Bruchertseifer, Frank, Schwaiger, Markus, Wester, Hans‐Jürgen, Notni, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813229/ https://www.ncbi.nlm.nih.gov/pubmed/28833667 http://dx.doi.org/10.1002/chem.201702335 |
Ejemplares similares
-
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics
por: Šimeček, Jakub, et al.
Publicado: (2018) -
First‐Generation Bispidine Chelators for (213)Bi(III) Radiopharmaceutical Applications
por: Bruchertseifer, Frank, et al.
Publicado: (2020) -
Therapeutic Radiopharmaceuticals Targeting Integrin
αvβ6
por: Färber, Stefanie Felicitas, et al.
Publicado: (2018) -
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013) -
Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors
por: Jung, Ji-hoon, et al.
Publicado: (2018)